Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide.
Identifieur interne : 004875 ( Main/Curation ); précédent : 004874; suivant : 004876Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide.
Auteurs : Ting-Wai Lee [Canada] ; Maia M. Cherney ; Carly Huitema ; Jie Liu ; Karen Ellis James ; James C. Powers ; Lindsay D. Eltis ; Michael N G. JamesSource :
- Journal of molecular biology [ 0022-2836 ] ; 2005.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
- chemical , chemistry : Cysteine Endopeptidases, Epoxy Compounds, Peptides, Protease Inhibitors.
- chemistry : SARS Virus.
- Binding Sites, Catalysis, Crystallography, X-Ray, Hydrogen-Ion Concentration, Molecular Structure.
Abstract
The main peptidase (M(pro)) from the coronavirus (CoV) causing severe acute respiratory syndrome (SARS) is one of the most attractive molecular targets for the development of anti-SARS agents. We report the irreversible inhibition of SARS-CoV M(pro) by an aza-peptide epoxide (APE; k(inact)/K(i) = 1900(+/-400) M(-1) s(-1)). The crystal structures of the M(pro):APE complex in the space groups C2 and P2(1)2(1)2(1) revealed the formation of a covalent bond between the catalytic Cys145 S(gamma) atom of the peptidase and the epoxide C3 atom of the inhibitor, substantiating the mode of action of this class of cysteine-peptidase inhibitors. The aza-peptide component of APE binds in the substrate-binding regions of M(pro) in a substrate-like manner, with excellent structural and chemical complementarity. In addition, the crystal structure of unbound M(pro) in the space group C2 revealed that the "N-fingers" (N-terminal residues 1 to 7) of both protomers of M(pro) are well defined and the substrate-binding regions of both protomers are in the catalytically competent conformation at the crystallization pH of 6.5, contrary to the previously determined crystal structures of unbound M(pro) in the space group P2(1).
DOI: 10.1016/j.jmb.2005.09.004
PubMed: 16219322
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002504
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :002504
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002767
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :001201
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :001201
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001201
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :004B86
Links to Exploration step
pubmed:16219322Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide.</title>
<author><name sortKey="Lee, Ting Wai" sort="Lee, Ting Wai" uniqKey="Lee T" first="Ting-Wai" last="Lee">Ting-Wai Lee</name>
<affiliation wicri:level="1"><nlm:affiliation>Canadian Institute of Health Research Group in Protein Structure and Function, Department of Biochemistry, University of Alberta, Edmonton, Alta., Canada T6G 2H7.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Canadian Institute of Health Research Group in Protein Structure and Function, Department of Biochemistry, University of Alberta, Edmonton, Alta.</wicri:regionArea>
<wicri:noRegion>Alta.</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cherney, Maia M" sort="Cherney, Maia M" uniqKey="Cherney M" first="Maia M" last="Cherney">Maia M. Cherney</name>
</author>
<author><name sortKey="Huitema, Carly" sort="Huitema, Carly" uniqKey="Huitema C" first="Carly" last="Huitema">Carly Huitema</name>
</author>
<author><name sortKey="Liu, Jie" sort="Liu, Jie" uniqKey="Liu J" first="Jie" last="Liu">Jie Liu</name>
</author>
<author><name sortKey="James, Karen Ellis" sort="James, Karen Ellis" uniqKey="James K" first="Karen Ellis" last="James">Karen Ellis James</name>
</author>
<author><name sortKey="Powers, James C" sort="Powers, James C" uniqKey="Powers J" first="James C" last="Powers">James C. Powers</name>
</author>
<author><name sortKey="Eltis, Lindsay D" sort="Eltis, Lindsay D" uniqKey="Eltis L" first="Lindsay D" last="Eltis">Lindsay D. Eltis</name>
</author>
<author><name sortKey="James, Michael N G" sort="James, Michael N G" uniqKey="James M" first="Michael N G" last="James">Michael N G. James</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:16219322</idno>
<idno type="pmid">16219322</idno>
<idno type="doi">10.1016/j.jmb.2005.09.004</idno>
<idno type="wicri:Area/PubMed/Corpus">002504</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002504</idno>
<idno type="wicri:Area/PubMed/Curation">002504</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002504</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002767</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002767</idno>
<idno type="wicri:Area/Ncbi/Merge">001201</idno>
<idno type="wicri:Area/Ncbi/Curation">001201</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001201</idno>
<idno type="wicri:doubleKey">0022-2836:2005:Lee T:crystal:structures:of</idno>
<idno type="wicri:Area/Main/Merge">004B86</idno>
<idno type="wicri:Area/Main/Curation">004875</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide.</title>
<author><name sortKey="Lee, Ting Wai" sort="Lee, Ting Wai" uniqKey="Lee T" first="Ting-Wai" last="Lee">Ting-Wai Lee</name>
<affiliation wicri:level="1"><nlm:affiliation>Canadian Institute of Health Research Group in Protein Structure and Function, Department of Biochemistry, University of Alberta, Edmonton, Alta., Canada T6G 2H7.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Canadian Institute of Health Research Group in Protein Structure and Function, Department of Biochemistry, University of Alberta, Edmonton, Alta.</wicri:regionArea>
<wicri:noRegion>Alta.</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cherney, Maia M" sort="Cherney, Maia M" uniqKey="Cherney M" first="Maia M" last="Cherney">Maia M. Cherney</name>
</author>
<author><name sortKey="Huitema, Carly" sort="Huitema, Carly" uniqKey="Huitema C" first="Carly" last="Huitema">Carly Huitema</name>
</author>
<author><name sortKey="Liu, Jie" sort="Liu, Jie" uniqKey="Liu J" first="Jie" last="Liu">Jie Liu</name>
</author>
<author><name sortKey="James, Karen Ellis" sort="James, Karen Ellis" uniqKey="James K" first="Karen Ellis" last="James">Karen Ellis James</name>
</author>
<author><name sortKey="Powers, James C" sort="Powers, James C" uniqKey="Powers J" first="James C" last="Powers">James C. Powers</name>
</author>
<author><name sortKey="Eltis, Lindsay D" sort="Eltis, Lindsay D" uniqKey="Eltis L" first="Lindsay D" last="Eltis">Lindsay D. Eltis</name>
</author>
<author><name sortKey="James, Michael N G" sort="James, Michael N G" uniqKey="James M" first="Michael N G" last="James">Michael N G. James</name>
</author>
</analytic>
<series><title level="j">Journal of molecular biology</title>
<idno type="ISSN">0022-2836</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Binding Sites</term>
<term>Catalysis</term>
<term>Crystallography, X-Ray</term>
<term>Cysteine Endopeptidases (chemistry)</term>
<term>Epoxy Compounds (chemistry)</term>
<term>Hydrogen-Ion Concentration</term>
<term>Molecular Structure</term>
<term>Peptides (chemistry)</term>
<term>Protease Inhibitors (chemistry)</term>
<term>SARS Virus (chemistry)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Catalyse</term>
<term>Composés époxy ()</term>
<term>Concentration en ions d'hydrogène</term>
<term>Cristallographie aux rayons X</term>
<term>Cysteine endopeptidases ()</term>
<term>Inhibiteurs de protéases ()</term>
<term>Peptides ()</term>
<term>Sites de fixation</term>
<term>Structure moléculaire</term>
<term>Virus du SRAS ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Cysteine Endopeptidases</term>
<term>Epoxy Compounds</term>
<term>Peptides</term>
<term>Protease Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Binding Sites</term>
<term>Catalysis</term>
<term>Crystallography, X-Ray</term>
<term>Hydrogen-Ion Concentration</term>
<term>Molecular Structure</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Catalyse</term>
<term>Composés époxy</term>
<term>Concentration en ions d'hydrogène</term>
<term>Cristallographie aux rayons X</term>
<term>Cysteine endopeptidases</term>
<term>Inhibiteurs de protéases</term>
<term>Peptides</term>
<term>Sites de fixation</term>
<term>Structure moléculaire</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The main peptidase (M(pro)) from the coronavirus (CoV) causing severe acute respiratory syndrome (SARS) is one of the most attractive molecular targets for the development of anti-SARS agents. We report the irreversible inhibition of SARS-CoV M(pro) by an aza-peptide epoxide (APE; k(inact)/K(i) = 1900(+/-400) M(-1) s(-1)). The crystal structures of the M(pro):APE complex in the space groups C2 and P2(1)2(1)2(1) revealed the formation of a covalent bond between the catalytic Cys145 S(gamma) atom of the peptidase and the epoxide C3 atom of the inhibitor, substantiating the mode of action of this class of cysteine-peptidase inhibitors. The aza-peptide component of APE binds in the substrate-binding regions of M(pro) in a substrate-like manner, with excellent structural and chemical complementarity. In addition, the crystal structure of unbound M(pro) in the space group C2 revealed that the "N-fingers" (N-terminal residues 1 to 7) of both protomers of M(pro) are well defined and the substrate-binding regions of both protomers are in the catalytically competent conformation at the crystallization pH of 6.5, contrary to the previously determined crystal structures of unbound M(pro) in the space group P2(1).</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004875 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 004875 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Curation |type= RBID |clé= pubmed:16219322 |texte= Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i -Sk "pubmed:16219322" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |